| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 10/13/2009 | US7601715 HIV inhibitors |
| 10/13/2009 | US7601695 11-N-[4-(4-Pyridin-3-yl-imidazol-1-yl)-butyl]-6-O-methyl-5-O-(3-dimethylamino-2-hydroxy-propoxy)-3-oxo-erythronolide A, 11,12-carbamate; functionalized macrolides; antiviral, antiprotozoal, anticancer and antigastrointestinal |
| 10/13/2009 | CA2473070C Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection |
| 10/13/2009 | CA2429844C Mch antagonists and their use in the treatment of obesity |
| 10/08/2009 | US20090253912 Process for the preparation of onium salts with a tetrafluoroborate anion having a reduced halide content |
| 10/08/2009 | US20090253908 Novel m3 muscarinic acetylchoine receptor antagonists |
| 10/08/2009 | US20090253907 Cyclopentadienyl, indenyl or fluorenyl substituted phosphine compounds and their use in catalytic reactions |
| 10/08/2009 | US20090253905 Process for the preparation of onium salts with alkyl- or arylsulfonate anions or alkyl- or arylcarboxylate anions having a low halide content |
| 10/08/2009 | US20090253703 Organic compounds |
| 10/08/2009 | US20090253701 such as (2S,4S,5S,7S)-5-Amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxy-propoxy)-benzyl]-8-methyl-nonanoic acid (2-phenoxy-ethyl)-amide, having renin-inhibiting properties, used for the treatment of hypertension, cardiovascular, vision, neurodegenerative, kidney and liver disorders |
| 10/08/2009 | US20090253690 N-[3-(1-piperidinyl)propoxy]-pyridin-1-oxide-3-carboxamidine; cardiovascular disorders; treating dysfunction of endothelial cells |
| 10/08/2009 | US20090253659 Cycloalkylidene Compounds As Modulators of Estrogen Receptor |
| 10/08/2009 | CA2720038A1 Novel donor-acceptor fluorene scaffolds: a process and uses thereof |
| 10/07/2009 | EP2107052A1 Novel n-(2-aminophenyl)benzamide derivative having an urea structure |
| 10/07/2009 | EP1000043B1 A crystalline dibenzothiazepine derivative and its use as an antipsychotic agent |
| 10/07/2009 | CN101550115A Novel substituted piperazinyl alkoxy bibenzyl compound, preparation method and medical application thereof |
| 10/07/2009 | CN100546977C New compounds for the inhibition of rotamases and use thereof |
| 10/07/2009 | CN100546976C Nitroaniline-based alkylating agents and their use as prodrugs |
| 10/06/2009 | US7598395 Heterocyclocarboxamide derivatives |
| 10/06/2009 | US7598386 Sulphones which modulate the action of gamma-secretase |
| 10/06/2009 | US7598378 Reacting 4-(4-nitrophenyl)-3-morpholinone with hydrogen in the presence of a hydrogenation catalyst, characterized in that reaction is effected in an aliphatic alcohol; precursor in synthesis of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide |
| 10/06/2009 | US7598269 3-(4-phenyl-1,2,3,6-tetrahydropyridin-1-yl)-1-propanesulfonic acid; reduces or inhibits amyloid fibril formation, organ specific dysfunction (e.g., neurodegeneration), or cellular toxicity |
| 10/06/2009 | US7598249 4-(3,4-dibromo-benzyl)-piperazine-1-carboxylic acid pyridin-3-ylamide; fatty acid amide hydrolase (FAAH) activity; anxiety, pain, inflammation, sleep disorders, eating disorders, or movement disorders such as multiple sclerosis |
| 10/06/2009 | US7598242 Compounds for the treatment of inflammatory disorders |
| 10/06/2009 | US7598241 Carboxamide derivatives and their use as factor Xa inhibitors |
| 10/06/2009 | US7598232 Amino-substituted (E)-2,6-dialkoxystyryl 4-substituted-benzylsulfones for treating proliferative disorders |
| 10/06/2009 | CA2326751C Method for producing grignard compounds |
| 10/06/2009 | CA2301377C N-aroylphenylalanine derivatives |
| 10/01/2009 | WO2009120492A1 Aromatic halsulfonyl isocyanate compositions and polymers therefrom |
| 10/01/2009 | WO2009118516A1 Process for the preparation of donepezil hydrochloride |
| 10/01/2009 | WO2009118327A1 1,4-naphthoquinone derivatives and therapeutic use thereof |
| 10/01/2009 | WO2009118292A1 Arylsulfonamide-based matrix metalloprotease inhibitors |
| 10/01/2009 | US20090247731 Boronic ester and acid compounds, synthesis and uses |
| 10/01/2009 | US20090247522 Hsp90 FAMILY PROTEIN INHIBITORS |
| 10/01/2009 | US20090247509 for treating central nervous system disorders such as psychological disorders, drug dependence and abuse, dyskinesia, dementia, anxiety disorders, sleep disorders and mood disorders |
| 10/01/2009 | US20090247506 Antibacterial agents |
| 10/01/2009 | US20090247499 Sulfonylated piperazines as cannabinoid-1 receptor modulators |
| 10/01/2009 | CA2719457A1 Arylsulfonamide-based matrix metalloprotease inhibitors |
| 10/01/2009 | CA2719164A1 Process for the preparation of donepezil hydrochloride |
| 09/30/2009 | EP2105441A1 Alanyl aminopeptidase and dipeptidylpeptidase IV dual inhibitors for the treatment of immunological, inflammatory, neuronal and other illnesses |
| 09/30/2009 | EP2105434A1 2-fluorinated acyl-3-aminoacrylonitrile derivative and method for producing the same |
| 09/30/2009 | EP2105134A1 Stable amorphous fexofenadine hydrochloride |
| 09/30/2009 | EP2104497A2 Urea and sulfamide derivatives as tafia inhibitors |
| 09/30/2009 | EP1776336B1 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them |
| 09/30/2009 | EP1658066B1 Adamantylglycine- based inhibitors of dipeptidyl peptidase iv for the treatment of diabetes |
| 09/30/2009 | CN101544629A Method for separating enantiomers of rotigotine and trihexyphenidyl |
| 09/30/2009 | CN101544619A Method for synthesizing Piberacine precursor |
| 09/30/2009 | CN101544618A Preparation method of piperazine derivatives with bioactivity |
| 09/30/2009 | CN101544617A Method for synthesizing ranolazine |
| 09/30/2009 | CN101544616A Novel method for synthesizing dyclonine hydrochloride |
| 09/30/2009 | CN101543788A Application of LnOTf3 in addition reaction of catalytic amine and carbodiimide |
| 09/30/2009 | CN100545152C Synthesis process of N-methyl morpholine |
| 09/29/2009 | US7595399 Tyrosine derivatives |
| 09/29/2009 | US7595344 Sulphones which modulate the action of gamma secretase |
| 09/29/2009 | US7595343 Inhibitors of histone deacetylase |
| 09/29/2009 | US7595319 Compounds having selective inhibiting effect at GSK3 |
| 09/29/2009 | US7595318 Conjugates which bind VLA-4; may also inhibit leukocyte adhesion; useful in the treatment of inflammatory diseases in a mammalian patient, such as asthma, Alzheimer's disease, atherosclerosis, AIDS, dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis |
| 09/29/2009 | US7595314 Such as (2-morpholin-4-yl-5-nitro-phenyl)-[4-(5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl]-methanone; for treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease |
| 09/29/2009 | US7595309 For therapy of bacterial infections and neoplasms, |
| 09/29/2009 | CA2391085C Bis-basic compounds as tryptase inhibitors, processes for preparing them and their use as phamaceutical compositions |
| 09/29/2009 | CA2375670C 5-phenyl-pyrimidine derivatives |
| 09/24/2009 | WO2009117594A1 Fluorinated macrocyclic compounds as hepatitis c virus inhibitors |
| 09/24/2009 | WO2009115393A1 Process for the preparation of n-(1-phenylethyl)anilines, salts, and solvates thereof useful as serotonin 5-ht6 antagonists |
| 09/24/2009 | WO2009115257A1 Substituted sulfonamide derivatives |
| 09/24/2009 | WO2009114987A1 Process for preparing repaglinide intermediate |
| 09/24/2009 | US20090239873 Phenyl-piperazine derivatives as modulators of muscarinic receptors |
| 09/24/2009 | US20090239869 Therapeutic substituted cyclopentanes |
| 09/24/2009 | US20090238773 Use of Morpholino Compounds for the Treatment of Halitosis |
| 09/24/2009 | CA2718713A1 Therapeutic compounds |
| 09/24/2009 | CA2718551A1 Substituted sulfonamide derivatives |
| 09/23/2009 | EP2103596A1 Process for the preparation of N-(phenylethyl) anilines salts and solvates thereof useful as serotonin 5-HT6 antagonists |
| 09/23/2009 | EP1590322B1 Carbonyl-amino substituted acyl phenyl urea derivatives, method for the production and use thereof |
| 09/23/2009 | EP1467989B1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatitis c virus infection |
| 09/23/2009 | EP1461038B9 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 09/23/2009 | CN101541774A Methods, mixtures, kits and compositions pertaining to analyte determination |
| 09/23/2009 | CN101538254A Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme |
| 09/23/2009 | CN101538253A Method for preparing repaglinide intermediate |
| 09/23/2009 | CN101538252A Novel preparation method and intermediate for aripiprazole |
| 09/23/2009 | CN101538244A 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity |
| 09/23/2009 | CN100543019C Process for preparing high purity roxatidine acetate and its salts |
| 09/23/2009 | CN100543017C Novel keto-oxadiazole derivatives as cathepsin inhibitors |
| 09/22/2009 | US7592466 Ureas having antiangiogenic activity |
| 09/22/2009 | US7592450 used to inhibit proliferative conditions, such as cancer and psoriasis, with improved bioavailability and stability |
| 09/22/2009 | CA2360894C (1-phenacyl-3-phenyl-3-piperidylethyl) piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same |
| 09/17/2009 | WO2009113677A1 A low-corrosion ion liquid and a lubricating oil composition including same |
| 09/17/2009 | WO2009113087A1 Montelukast benzhydryl piperazine salts and process for preparation thereof |
| 09/17/2009 | WO2009076399A3 Aminotetralin compounds as mu opioid receptor antagonists |
| 09/17/2009 | US20090233921 Therapeutic cyclopentane derivatives |
| 09/16/2009 | EP2100890A1 Novel polynitrogenated systems as anti-hiv agents |
| 09/16/2009 | EP2100876A2 New compounds for the inhibition of rotamases and use thereof |
| 09/16/2009 | EP2099748A1 Insecticidal benzamidines |
| 09/16/2009 | EP1858865B1 Substituted n-sulfonylaminophenylethyl-2-phenoxy acetamide compounds |
| 09/16/2009 | EP1608635B1 Phenyl sulfone derivatives and their use in the treatment of cns disorders |
| 09/16/2009 | EP1578737B1 Substituted heterocyclic compounds |
| 09/16/2009 | EP1523471B1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 09/16/2009 | CN101531643A Synthesis method for improved cinepazide maleate |
| 09/16/2009 | CN101531642A Method for preparing pinaverium bromide and application thereof |
| 09/16/2009 | CN101531599A Green electroluminescent compounds and organic electroluminescent device using the same |
| 09/16/2009 | CN100540547C Inhibitors of histone deacetylase |
| 09/15/2009 | US7589127 Aminoalkylphenols, methods of using and making the same |